Table 4 Summary of changes (baseline – follow-up) in clinical measures (mean, 95% CI) ^a

CVD risk (%)

3.10^b

2.80^b

2.98^b

(2.43, 3.76)

(2.01, 3.58)

(2.47, 3.48)

Systolic blood pressure (mmHg)

6.65^b

5.64^b

6.25^b

(4.94, 8.36)

(3.74, 7.53)

(4.98, 7.53)

Diastolic blood pressure (mmHg)

3.56^b

3.31^b

3.47^b

(2.61, 4.52)

(2.25, 4.38)

(2.76, 4.18)

Total cholesterol (mmol/l)

0.54^b

0.56^b

0.55^b

(0.45, 0.64)

(0.44, 0.68)

(0.47, 0.62)

High density lipoproteins (mmol/l)

−0.01

−0.01

−0.01

(−0.03, 0.00)

(−0.03, 0.01)

(−0.03, 0.00)

Total cholesterol/HDL ratio

0.42^b

0.47^b

0.44^b

(0.33, 0.51)

(0.35, 0.59)

(0.37, 0.51)

Weight (kg)

0.23

0.51

0.34

(−0.24, 0.70)

(−0.21, 1.24)

(−0.06, 0.74)

Body mass index (kgm^-2)

0.02

0.22^d

0.10^c

(−0.13, 0.17)

(−0.03, 0.47)

(−0.04, 0.23)

Waist circumference (cm)

1.19^b

1.61^b

1.36^b

(0.60, 1.78)

(0.90, 2.32)

(0.90, 1.81)